公司資料
Icosavax 股價、新聞與催化劑
- 股票代碼:
- ICVX
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股價為何變動
Current closing-price context is not available for ICVX.
公司概覽
業務概覽
Icosavax was a vaccine biotechnology company focused on next-generation respiratory vaccines before its acquisition by AstraZeneca. Its platform combined structural biology and vaccine design.
所在地與產業分類
Headquartered in the United States and listed on NASDAQ before acquisition, Icosavax sat in vaccine biotechnology.
商業模式特徵
The business depended on clinical data, immunogenicity, and the value of its vaccine design platform.
生技產業定位
Icosavax was a vaccine-platform name and now belongs to biotech M&A history.
未來催化劑
- Icosavax is now mostly a transaction closeout and integration story, so the remaining catalysts are any wind-down or post-deal milestone. There is no live standalone pipeline story left to drive the name.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。